Literature DB >> 33144455

Dominant Antibiotic Consumption Patterns Might Be Associated With the Prevalence of Multiple Sclerosis in European Countries.

GÁbor TernÁk1, KÁroly BerÉnyi2, Gergely MÁrovics2, AndrÁs SÜmegi2, Barbara Fodor2, BalÁzs NÉmeth2, IstvÁn Kiss2.   

Abstract

BACKGROUND/AIM: With a prevalence of 50-300 per 100,000 people, about 2.3 million people are estimated to live with multiple sclerosis (MS) globally. The role of antibiotics in the development, or prevention of MS is controversial. We aimed to elucidate the association between antibiotic consumption and MS. PATIENTS AND METHODS: Pearson statistical comparisons were performed between the annual average antibiotic consumption patterns expressed in Defined Daily Dose/1,000 inhabitants/Day of the antibiotic consumption for the years of 1997-2018 in 30 European countries, with the respective prevalence of MS estimated for 2016.
RESULTS: A positive correlation (promoting effect) has been observed between narrow spectrum penicillin (r=0.636) and tetracycline (r=0.412) consumption with MS prevalence.
CONCLUSION: Countries, with high consumption of narrow spectrum penicillin and tetracycline, experience a higher prevalence of MS than other countries. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Antibiotic consumption; multiple sclerosis; penicillin; tetracycline

Mesh:

Substances:

Year:  2020        PMID: 33144455      PMCID: PMC7811631          DOI: 10.21873/invivo.12186

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  14 in total

Review 1.  Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.

Authors:  Howard L Weiner
Journal:  Arch Neurol       Date:  2004-10

Review 2.  Nature plus nurture: the triggering of multiple sclerosis.

Authors:  Hartmut Wekerle
Journal:  Swiss Med Wkly       Date:  2015-10-02       Impact factor: 2.193

Review 3.  Multiple sclerosis.

Authors:  Alan J Thompson; Sergio E Baranzini; Jeroen Geurts; Bernhard Hemmer; Olga Ciccarelli
Journal:  Lancet       Date:  2018-03-23       Impact factor: 79.321

4.  Gut microbiota in early pediatric multiple sclerosis: a case-control study.

Authors:  Helen Tremlett; Douglas W Fadrosh; Ali A Faruqi; Feng Zhu; Janace Hart; Shelly Roalstad; Jennifer Graves; Susan Lynch; Emmanuelle Waubant
Journal:  Eur J Neurol       Date:  2016-05-13       Impact factor: 6.089

5.  Antibiotic use and risk of multiple sclerosis.

Authors:  Alvaro Alonso; Susan S Jick; Hershel Jick; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2006-04-05       Impact factor: 4.897

6.  Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis.

Authors:  Luanne M Metz; David K B Li; Anthony L Traboulsee; Pierre Duquette; Misha Eliasziw; Graziela Cerchiaro; Jamie Greenfield; Andrew Riddehough; Michael Yeung; Marcelo Kremenchutzky; Galina Vorobeychik; Mark S Freedman; Virender Bhan; Gregg Blevins; James J Marriott; Francois Grand'Maison; Liesly Lee; Manon Thibault; Michael D Hill; V Wee Yong
Journal:  N Engl J Med       Date:  2017-06-01       Impact factor: 91.245

7.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

Authors:  Kerstin Berer; Lisa Ann Gerdes; Egle Cekanaviciute; Xiaoming Jia; Liang Xiao; Zhongkui Xia; Chuan Liu; Luisa Klotz; Uta Stauffer; Sergio E Baranzini; Tania Kümpfel; Reinhard Hohlfeld; Gurumoorthy Krishnamoorthy; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study.

Authors:  I Abdollahpour; S Nedjat; M A Mansournia; S Eckert; B Weinstock-Guttman
Journal:  Acta Neurol Scand       Date:  2018-05-09       Impact factor: 3.209

Review 10.  The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue.

Authors:  Trevor O Kirby; Javier Ochoa-Repáraz
Journal:  Med Sci (Basel)       Date:  2018-08-24
View more
  1 in total

1.  Antibiotic Consumption Patterns in European Countries Might Be Associated with the Prevalence of Type 1 and 2 Diabetes.

Authors:  Gábor Ternák; Márton Németh; Martin Rozanovic; Lajos Bogár
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.